Cargando…
Continuous Quinacrine Treatment Results in the Formation of Drug-Resistant Prions
Quinacrine is a potent antiprion compound in cell culture models of prion disease but has failed to show efficacy in animal bioassays and human clinical trials. Previous studies demonstrated that quinacrine inefficiently penetrates the blood-brain barrier (BBB), which could contribute to its lack of...
Autores principales: | Ghaemmaghami, Sina, Ahn, Misol, Lessard, Pierre, Giles, Kurt, Legname, Giuseppe, DeArmond, Stephen J., Prusiner, Stanley B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777304/ https://www.ncbi.nlm.nih.gov/pubmed/19956709 http://dx.doi.org/10.1371/journal.ppat.1000673 |
Ejemplares similares
-
Pharmacokinetics of Quinacrine Efflux from Mouse Brain via the P-glycoprotein Efflux Transporter
por: Ahn, Misol, et al.
Publicado: (2012) -
Pharmacokinetics of quinacrine in the treatment of prion disease
por: Yung, Lotus, et al.
Publicado: (2004) -
Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice
por: Nazor Friberg, Karah, et al.
Publicado: (2012) -
Conserved properties of human and bovine prion strains on transmission to guinea pigs
por: Safar, Jiri G., et al.
Publicado: (2011) -
Evidence That Bank Vole PrP Is a Universal Acceptor for Prions
por: Watts, Joel C., et al.
Publicado: (2014)